According to IPA disease comparison analysis, C498 alleviated a variety of inflammatory diseases including shock response, systemic inflammatory response, lung injury, rheumatic diseases, acute colitis, inflammatory bowel disease, and inflammation of respiratory system, not to mention the pivotal roles of JAK/STAT and NFκB signaling pathways in these inflammatory diseases. Here, NFKB1 is linked to inflammatory bowel disease.